Amrutanjan Health Care (BOM:590006) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:590006 Amrutanjan Health Care Ltd BOM:590006
71 GF Score
Price ₹490.35
GF Value ₹827.69
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Amrutanjan Health Care FFO?

FFO (Funds from operations) only applies to REITs.

BOM:590006
71GF Score
Amrutanjan Health Care Ltd BOM:590006
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Amrutanjan Health Care (BOM:590006) Overvalued in 2026?

Based on GuruFocus' analysis, Amrutanjan Health Care stock appears to be undervalued. The current stock price of ₹490.35 is trading 40.8% below its estimated GF Value™ of ₹827.69. GuruFocus considers Amrutanjan Health Care to be Significantly Undervalued.

Key valuation signals for BOM:590006:

  • FFO:
  • GF Value™: ₹827.69 vs. price of ₹490.35 (40.8% below fair value)
  • GF Score™: 71/100 with 3 warning signs

No single metric tells the full story. See the BOM:590006 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Amrutanjan Health Care Business Description

Other Exchanges AMRUTANJAN:India
Address No. 103 (Old No. 42-45), Luz Church Road, Mylapore, Chennai, TN, IND, 600 004
Amrutanjan Health Care Ltd manufactures Ayurvedic and allopathic products. The company operates through the following segments: OTC Products, Beverages, and Others. The majority of the revenue is generated from its OTC segment which is engaged in the manufacturing products of pain management, congestion management, and hygiene. Its beverage segment includes manufacturing fruit juices and oral rehydration drinks. Some of its products include Roll-on, Spray, Balm, Cough Syrup, Sanitary napkins, and inhalers. Geographically, it generates the majority of the revenue from India.
71GF Score

Get the complete analysis for BOM:590006

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹490.35
Price
₹827.69
GF Value